Clinical Trial Site

Leeds LS26 9AA

1 studies enrolling now · 4 studies all time

What they study most

ANCA-Associated Vasculitis, Elevated Urinary Oxalate Levels, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Paroxysmal Nocturnal Hemoglobinuria, Recurrent Calcium Oxalate Kidney Stone Disease

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels — Stopped early
• A Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal Hemoglobinuria — Completed